在阿尔茨海默氏症和帕金森病中模拟神经免疫系统
Wendy Balestri1,2, Ruchi Sharma3,4,5, Victor A da Silva3,4,5
1Department of Engineering, School of Science and Technology, Nottingham Trent University, Nottingham, UK.
Journal of neuroinflammation
|January 23, 2024
概括
先进的3D和器官芯片模型为帕金森氏症的神经免疫系统相互作用提供了更准确的表征.
科学领域:
- 神经免疫学 神经免疫学
- 神经退行性疾病研究
背景情况:
- 帕金森病 (PD) 和阿尔茨海默病 (AD) 是复杂的神经退行性疾病,受遗传,环境和家族因素的影响.
- 神经免疫系统中的微质功能障碍是神经元损失和PD和AD症状恶化的关键因素.
研究的目的:
- 探索先进的体外模型对研究神经退行性疾病的有用性.
- 突出3D和器官芯片系统在PD和AD研究中模拟神经免疫系统的潜力.
主要方法:
- 利用各种体外和体内模型,包括2D培养和动物模型.
- 专注于优化现有模型和开发新型3D和器官芯片系统的最新进展.
主要成果:
- 与2D模型相比,3D和器官芯片模型提供了更现实的细胞内环境模拟.
- 这些先进的模型增强了细胞活力,并为长期疾病建模和治疗测试提供了潜力.
结论:
- 优化的3D和器官芯片模型代表了神经退行性疾病研究的重大突破.
- 这些模型有望减少对动物试验的依赖,并改善治疗PD和AD等神经免疫疾病的治疗方法的开发.
更多相关视频
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.0K
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
相关概念视频
Parkinson's Disease: Overview
547
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487
